Esophageal cancer: A global challenge requiring tailored strategies

doi:10.4251/wjgo.v16.i7.2881

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (179)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

158

Sum=165

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=8

Jul 15, 2024 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2881-2883
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2881

Esophageal cancer: A global challenge requiring tailored strategies

Chun-Yao Cheng, Wen-Rui Hao, Tzu-Hurng Cheng

Chun-Yao Cheng, Department of Medical Education, National Taiwan University Hospital, Taipei 100225, Taiwan

Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei 23561, Taiwan

Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11002, Taiwan

Tzu-Hurng Cheng, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung 404333, Taiwan

Co-first authors: Chun-Yao Cheng and Wen-Rui Hao.

Author contributions: Cheng CY and Hao WH contributed equally; Cheng CY wrote the paper; Hao WH and Cheng TH revised the paper; All authors have read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404333, Taiwan. thcheng@mail.cmu.edu.tw

Received: February 24, 2024
Revised: April 25, 2024
Accepted: May 14, 2024
Published online: July 15, 2024
Processing time: 138 Days and 17.3 Hours

Core Tip

Core Tip: Regional disparities and histological variations in esophageal cancer underscore the importance of tailored screening and treatment strategies. Customized screening protocols, advancements in imaging technologies, and integration of biomarkers are promising avenues for early detection and precision treatment. Embracing a multidisciplinary approach and technological innovations is crucial for improving outcomes in esophageal cancer management globally.